Tímarit hjúkrunarfræðinga - 01.10.2012, Blaðsíða 51

Tímarit hjúkrunarfræðinga – 4. tbl. 88. árg. 2012 47
Ritrýnd fræðigrein
SCIENTIFIC PAPER
Krueger, G., Koo, J., Lebwohl, M., Menter, A., Stern, R., og Rolstad,
T. (2001). The impact of psoriasis on quality of life: Result of a
1998 psoriasis foundation patient membership survey. Archives of
Dermatology, 137 (3), 280­284.
Leman, J. A., og Burden, A. D. (2008). Treatment of severe psoriasis with
infliximab. Therapeutics and clinical risk management, 4 (6), 1165­1175.
Lima, X. T., Seidler, E. M., Lima, H. C., og Kimball, A. B. (2009). Long­term
safety of biologics in dermatology. Dermatologic Therapy, 22, 2­21.
Magin, P., Adams, J., Heading, G., Pound, D., og Smith, W. (2009). The
psychological sequelae of psoriasis: Results of a qualitative study.
Psychology, Health & Medicine, 14 (2), 150­161.
Mallbris, L., Ritchlin, C. T., og Ståhle, M. (2006). Metabolic disorders in
patients with psoriasis and psoriatic arthritis. Rhematology Reports, 8,
365­363.
Menter, A., Smith, C., og Barker, J. (2004). Psoriasis (2. útgáfa). Oxford: Fine
Print Oxford.
Menter, A., Gottlieb, A., Feldman, S.R., Van Voorhees, A. S., Leonardi, C.
L., Gordon, K. B., o.fl. (2008). Guidelines of care for the management
of psoriasis and psoriasis arthritis: Section 1. Overview of psoriasis and
guidelines of care for the treatment of psoriasis with biologics. Journal of
the American Academy of Dermatology, 58 (5), 826­850.
Munhall P. L. (2007). Nursing research: A qualitative perspective (3. útgáfa).
Massachusetts: Jones and Barlett Publishers.
Pearce, D. J., Boles, A., Greist, H. M., og Feldman, S. R. (2005). Biologic
therapy for psoriasis: Telephone triage. Dermatology Nursing, 17 (4).
265­295.
Rapp, S. R., Feldman, S., Exum, M. L., Fleischer, A. B., og Reboussin, D.
M. (1999). Psoriasis causes as much disability as other major medical
diseases. Journal of the American Academy of Dermatology, 41 (3), 401­
407.
Sampogna, F., Gisondi, P., Tabolli, S., og Abeni, D. (2007). Impairment of
sexual life in patients with psoriasis. Dermatology, 214 (2), 144­150.
SIGN, Scottish Intercollegiate Guidelines Network. (2009, september).
Diagnosis and management of psoriasis and psoriatic arthritis in adults:
A national clinical guideline. Sótt af http://www.sign.ac.uk/pdf/psoriasis­
draft.pdf
Uttjek, M., Nygren, L., Stenberg, B., og Dufåker, M. (2007). Marked by
visibility of psoriasis in everyday life. Qualitative health Research, 17 (3),
364­372.
van Manen, M. (1990). Researching lived experience: Human science for an
action sensitive pedagogy. New York: University of New York Press.
Vardy, D., Besser. A., Amir, M., Gesthalter, B., Biton, A., og Buskila, D.
(2002). Experiences of stigmatization play a role in mediating the impact
of disease severity on quality of life in psoriasis patients. British Journal of
Dermatology, 147 (4), 736­742.
Wahl, A. K., Gjengedal, E., og Hanestad, B. R. (2002). The bodily suffering
of living with severe psoriasis: In­depth interviews with 22 hospitalized
patients with psoriasis. Qualitative Health Research, 12 (2), 250­261.
Watson, T., og Bruin, G. P. (2007). Impact of cutaneous disease on the self
concept: An Existential­phenomenological study of men and women with
psoriasis. Dermatology Nursing, 19 (4), 351­364.
Weiss, S. C., Kimball, A. B., Liewehr, D. J., Blauvelt, A., Turner, M. L.,
og Emanuel, E. J. (2002). Quantifying the harmful effect of psoriasis
on health­related quality of life. Journal of the American Academy of
Dermatology, 47, 512­518.